Search

The article focuses on reproductive carrier screening during pregnancy and its implications for both maternal and fetal health. It discusses the importance of carrier screening, identifies conditions with potential maternal manifestations, and highlights the role of healthcare providers in supporting individuals through this process.

A new prenatal test that indirectly quantifies fetal DNA in maternal plasma has been shown to be highly sensitive in detecting trisomy 21 and has the potential to identify other forms of fetal aneuploidy. [ABSTRACT FROM AUTHOR]

The article offers information related to contemporary management of twins in terms of obstetrics. It notes that due to reproductive technology being more widely used, the incidence of twins has increased to 1 in 20 pregnancies. It discusses the most common problems affecting twins including anomalies, preterm labor (PTL), and twin-to-twin discordance (TTD). Information on prenatal testing is provided.

The article presents information on a controversy related to prenatal testing for birth defects control. Rick Santorum, a republican presidential candidate, states that the rules related to prenatal testing should be changed as it will reduce the populations of disability in the society. According to the American Medical Association the use of next generation sequencing will detect large number of harmful genetic variants and it will also expand the number of pediatric disorders.

The authors of this two-center study found that magnetic resonance is not superior to ultrasound in diagnostic accuracy for placenta accreta spectrum disorders, and its usefulness is tempered particularly by a tendency to falsely upgrade the stage of severity. [ABSTRACT FROM AUTHOR]

The article focuses on study on relevance of noninvasive prenatal testing (NIPT) with cell-free DNA when screening for fetal aneuploidy. Topics discussed include first trimester nuchal translucency screening along with biochemical markers, multiple marker (standard) methods having the highest detection rates at the lowest cost for all chromosomal abnormalities and NIPT being expensive and not detecting all types of aneuploidy.

A single prenatal testing center with a large volume of patients has experienced a dramatic drop in the rate of chorionic villus sampling and amniocentesis after the introduction of noninvasive prenatal testing. [ABSTRACT FROM AUTHOR]

In diagnostic amniocentesis and chorionic villus sampling, microarray detects a wider breadth of clinically meaningful chromosomal abnormalities than standard karyotype. [ABSTRACT FROM AUTHOR]

A recent study suggests that infants between 34-39 weeks gestation with immature amniotic fluid lung profiles who are managed expectantly have lower rates of adverse neonatal respiratory outcomes as well as lower rates of overall morbities when compared to infants that are delivered after a course of steroids. [ABSTRACT FROM AUTHOR]

A recent study supports another investigation suggesting the benefit of a rescue dose of antenatal corticosteroids in patients who will deliver prior to 35 weeks and have had more than 2 weeks elapse after their initial course of therapy. [ABSTRACT FROM AUTHOR]

The article discusses the advantages of medical technologies such as medically indicated scan (MEU) and non-medical entertainment ultrasound (NEU). Based on experimental studies, the method is highly recommended by the physicians as a diagnostic approach to pregnant women due to its less contribution of ultraviolet radiation. The author emphasized the lifesaving and life-altering management for the health benefits to the pregnant mothers and fetus.